Register entryRepackager / relabeller
Geron Corporation
- Registered sites
- 1
- Drug products
- 2
- Live patents
- 12
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Labelling
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Geron Corporation | Foster City, CAUnited States | Labelling | 3016772438 |
Exclusivity
Patents
12Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| RYTELO | IMETELSTAT SODIUM | Sept 2026 |
| RYTELO | IMETELSTAT SODIUM | Dec 2026 |
| RYTELO | IMETELSTAT SODIUM | Mar 2033 |
| RYTELO | IMETELSTAT SODIUM | Jun 2039 |
Catalogue
Marketed products
2Showing 2 of 2.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| RYTELO | imetelstat sodium | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| RYTELO | imetelstat sodium | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.